Table of Contents
ISRN Chromatography
Volume 2012, Article ID 278583, 7 pages
http://dx.doi.org/10.5402/2012/278583
Research Article

Stability-Indicating High-Performance Thin-Layer Chromatographic Method for Quantitative Estimation of Emtricitabine in Bulk Drug and Pharmaceutical Dosage Form

Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Pune 411038, India

Received 10 February 2012; Accepted 25 March 2012

Academic Editors: M. Palma and A. I. Suarez

Copyright © 2012 Atul S. Rathore et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Bodavari, The Merck Index, Monograph no. 3565, Whitehouse Station, 14th edition, 2006.
  2. L. M. Bang and L. J. Scott, “Emtricitabine: an antiretroviral agent for HIV infection,” Drugs, vol. 63, no. 22, pp. 2413–2424, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. P. T. Nagaraju, K. P. Channabasavaraj, and P. T. Shantha Kumar, “Development and validation of spectrophotometric method for estimation of emtricitabine in tablet dosage form,” International Journal of ChemTech Research, vol. 3, no. 1, pp. 23–28, 2011. View at Google Scholar · View at Scopus
  4. A. Karunakaran, K. Kamarajan, and V. Thangarasu, “Simultaneous determination of emtricitabine and tenofovir disoproxil fumerate in tablet dosage form by UV-spectrophotometry,” Asian Journal of Chemistry, vol. 23, no. 6, pp. 2719–2721, 2011. View at Google Scholar · View at Scopus
  5. K. Anandakumar, K. Kannan, and T. Vetrichelvan, “Development and validation of emtricitabine and tenofovir disoproxil fumerate in pure and in fixed dose combination by UV spectrophotometry,” Digest Journal of Nanomaterials and Biostructures, vol. 6, no. 3, pp. 1085–1090, 2011. View at Google Scholar · View at Scopus
  6. V. K. Kumar and N. A. RAjut, “Estimation of emtricitabine in tablet dosage form by RP-HPLC,” Asian Journal of Chemistry, vol. 21, no. 8, pp. 5979–5983, 2009. View at Google Scholar · View at Scopus
  7. N. A. Raju, J. V. Rao, K. V. Prakash, K. Mukkanti, and K. Srinivasu, “Simultaneous estimation of tenofovir disoproxil, emtricitabine and efavirenz in tablet dosage form by RP-HPLC,” Oriental Journal of Chemistry, vol. 24, no. 2, pp. 645–650, 2008. View at Google Scholar · View at Scopus
  8. U. Seshachalam, B. Haribabu, and K. B. Chandrasekhar, “Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance,” Journal of Separation Science, vol. 30, no. 7, pp. 999–1004, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. H. Droste, R. E. Aarnoutse, and D. M. Burger, “Determination of emtricitabine in human plasma using HPLC with fluorometric detection,” Journal of Liquid Chromatography & Related Technologies, vol. 30, no. 18, pp. 2769–2778, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Notari, A. Bocedi, G. Ippolito et al., “Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography,” Journal of Chromatography B, vol. 831, no. 1-2, pp. 258–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. N. L. Rezk, R. D. Crutchley, and A. D. M. Kashuba, “Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction,” Journal of Chromatography B, vol. 822, no. 1-2, pp. 201–208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Joshi, A. P. Nikalje, M. Shahed, and M. Dehghan, “HPTLC method for the simultaneous estimation of emtricitabine and tenofovir in tablet dosage form,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 1, pp. 95–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Delahunty, L. Bushman, B. Robbins, and C. V. Fletcher, “The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards,” Journal of Chromatography B, vol. 877, no. 20-21, pp. 1907–1914, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. N. A. Gomes, V. V. Vaidya, A. Pudage, S. S. Joshi, and S. A. Parekh, “Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 3, pp. 918–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. International Conference on Harmonization ICH Q1A, Stability Testing of New Drug Substances and Products, ICH, Geneva, Switzerland, 1993.
  16. P. D. Sethi, High Performance Thin Layer Chromatography: Quantitative Analysis of Pharmaceutical Formulations, CBS Publishers and Distributors, New Delhi, India, 2nd edition, 1996.
  17. M. V. Mahadik, S. R. Dhaneshwar, and M. J. Kulkarni, “Application of stability indicating HPTLC method for quantitative determination of Escitalopram oxalate in pharmaceutical dosage form,” Eurasian Journal of Analytical Chemistry, vol. 2, no. 2, pp. 101–117, 2007. View at Google Scholar
  18. International Conference on Harmonization ICH Q2 (R1), Validation of Analytical Procedures: Text and Methodology, The International Federation of Pharmaceutical Manufacturers & Associations, Geneva, Switzerland, 2005.